How often must the Board of Pharmacy report to the Board of Optometry regarding complaints related to the administration of legend drugs?

Disable ads (and more) with a membership for a one time $4.99 payment

Study for the Minnesota MPJE. Use practice exams and multiple choice questions with detailed explanations. Prepare effectively for success!

The Minnesota Board of Pharmacy is required to report to the Board of Optometry on a quarterly basis regarding any complaints related to the administration of legend drugs. This requirement ensures that both boards maintain effective communication regarding any issues that may arise in the practice of optometry, particularly concerning the use and administration of legend drugs that optometrists may prescribe or dispense. Regular quarterly reporting provides a structured approach for addressing potential problems and allows for timely intervention and oversight in maintaining patient safety and adherence to regulations.

The other choices do not align with this mandated reporting frequency and would not support the necessary oversight and collaborative efforts between the pharmacy and optometry boards to ensure compliance and protect public health.